The sequencing of partial human expressed genes and of microbial genom
es is leading to the discovery of many new targets for drug discovery.
As more targets become known, drugs can be designed that have greater
selectivity than was possible using traditional pharmacological metho
ds. The promise of the new approach is that drugs discovered in this w
ay will be highly efficacious and will have a reduced tendency for unw
anted side-effects.